Cargando…
Screening analysis of ubiquitin ligases reveals G2E3 as a potential target for chemosensitizing cancer cells
Cisplatin is widely used against various tumors, but resistance is commonly encountered. By inducing DNA crosslinks, cisplatin triggers DNA damage response (DDR) and cell death. However, the molecular determinants of how cells respond to cisplatin are incompletely understood. Since ubiquitination pl...
Autores principales: | Schmidt, Franziska, Kunze, Meike, Loock, Ann-Christine, Dobbelstein, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359243/ https://www.ncbi.nlm.nih.gov/pubmed/25593194 |
Ejemplares similares
-
Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity
por: Frankum, Jessica, et al.
Publicado: (2015) -
Identification of Smurf2 as a HIF-1α degrading E3 ubiquitin ligase
por: Zhao, Shuai, et al.
Publicado: (2021) -
Mdm2 inhibition confers protection of p53-proficient cells from the cytotoxic effects of Wee1 inhibitors
por: Li, Yizhu, et al.
Publicado: (2015) -
G2E3 attenuating replicative stress
por: Schmidt, Franziska, et al.
Publicado: (2015) -
MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells
por: Cimas, Francisco J., et al.
Publicado: (2015)